Navegar por autor "Blanco Aparicio, Marina"

Mostrando ítems 1-8 de 8

Efficacy and safety of two inhaled tobramycin solutions in patients with cystic fibrosis and chronic pseudomonas aeruginosa infection: Results from a head to head comparison

2011- Blanco Aparicio, Marina
Eradication of Pseudomonas aeruginosa with inhaled colistin in adults with non-cystic fibrosis bronchiectasis

2019- Blanco Aparicio, Marina; Saleta Canosa, Jesús Luis; Valiño Lopez, Paz; Martin Egaña, Teresa; VIDAL GARCIA, IRIA; [et al.]
Eradication of Pseudomonas aeruginosa with inhaled colistin in adults with non-cystic fibrosis bronchiectasis.

2019- Blanco Aparicio, Marina; Saleta Canosa, Jesús Luis; Valiño Lopez, Paz; Martin Egaña, Teresa; VIDAL GARCIA, IRIA; [et al.]
Impact of Pseudomonas aeruginosa Infection on Patients with Chronic Inflammatory Airway Diseases

2020- Garcia-Clemente, Marta; de la Rosa, David; Máiz, Luis; Girón, Rosa; Blanco Aparicio, Marina; [et al.]
Long-term efficacy and safety of aerosolized tobramycin 300mg/4ml in cystic fibrosis

2014- Blanco Aparicio, Marina
Nocardiosis pulmonar tratada con tedizolid

2019- Giménez Arufe, Víctor; Gutierrez Urbon, José; Blanco Aparicio, Marina; Míguez Rey, Enrique; Martín Herranz, Isabel [et al.]
Qué no se debe hacer en el manejo terapéutico del asma bronquial. Recomendaciones por consenso Delphi para los médicos que tratan el asma

2021- Román Rodríguez, Miguel; Ginel Mendoza, Leovigildo; Blanco Aparicio, Marina; Rodríguez Rodríguez, Mercedes; Bárcena Caamaño, Mario [et al.]
Utility of brief questionnaires of health-related quality of life (Airways Questionnaire 20 and Clinical COPD Questionnaire) to predict exacerbations in patients with asthma and COPD

2013- Pita Fernandez, Salvador; Pertega Diaz, Sonia; Verea Hernando, Hector; Blanco Aparicio, Marina